Skills over pills? A clinical gastroenterologist's primer in cognitive behavioral therapy for irritable bowel syndrome.

Expert Review of Gastroenterology & Hepatology
Jeffrey M Lackner

Abstract

Irritable bowel syndrome is a common, painful, and often disabling GI disorder for which there is no satisfactory medical or dietary treatment. The past 10 years have seen the development and validation of a number of psychological treatments of which CBT is arguably the most effective based on two recently conducted multiple site trials from two investigative teams in the UK and USA. The purpose of this review is to describe the principles, processes, procedures, and empirical basis supporting CBT and distinguish it from other psychological treatments available to clinical GE whose patients suffer from refractory IBS. The efficacy of CBT in treating refractory IBS patients is well established but there is limited understanding of why it works and for whom it is most beneficial. Further, its availability is generally limited to tertiary care settings which may undermine its value proposition if improved self-management is not accompanied by other health-care efficiencies. Systematic efforts to increase both the efficiency of CBT and the way it is delivered (e.g. digital therapeutics, integration into primary care) is critical to optimizing CBT's potential and reducing the public health burden IBS imposes.

References

Sep 10, 1983·Lancet·J SvedlundG Dotevall
Aug 1, 1984·Archives of General Psychiatry·F M QuitkinJ W Stewart
Jan 1, 1983·Acta Psychiatrica Scandinavica. Supplementum·J Svedlund
Nov 15, 1995·Annals of Internal Medicine·D A DrossmanM A Barreiro
Jan 1, 1994·American Journal of Psychotherapy·P A Dewald
Sep 1, 1993·The British Journal of Psychiatry : the Journal of Mental Science·E GuthrieB Tomenson
Jul 22, 1998·Psychological Bulletin·B F Chorpita, D H Barlow
Jun 1, 2002·Behaviour Research and Therapy·L Keefer, E B Blanchard
Jan 31, 2003·Gastroenterology·Francis CreedUNKNOWN North of England IBS Research Group
Jun 30, 2004·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Margaret M HeitkemperPam Weisman
Dec 23, 2004·Journal of Consulting and Clinical Psychology·Jeffrey M LacknerSimon Hamilton
May 19, 2005·Bulletin of the Menninger Clinic·Peter FonagyAnna Higgitt
Dec 13, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·Sofia Avissar, Gabriel Schreiber
Jun 15, 2007·Applied Psychophysiology and Biofeedback·Kathryn Amelia SandersMark A Sykes
Jun 6, 2008·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Jeffrey M LacknerKenneth Holroyd
Jul 3, 2009·Behaviour Research and Therapy·Melissa G HuntMarina Milonova
Jul 4, 2009·Annual Review of Psychology·Charles S Carver, Jennifer Connor-Smith
Feb 23, 2010·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Jeffrey M LacknerLeonard A Katz
Nov 26, 2010·Annual Review of Medicine·Emeran A Mayer, Kirsten Tillisch
Nov 26, 2010·Behaviour Research and Therapy·Brjánn LjótssonChristian Rück
Mar 12, 2011·Journal of Medical Internet Research·David C MohrKenneth Lehman
May 4, 2011·The American Journal of Gastroenterology·Brjánn LjótssonGerhard Andersson
May 14, 2011·Behaviour Research and Therapy·Michelle G CraskeBruce D Naliboff
Aug 30, 2011·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Uri LadabaumTheodore R Levin
Oct 30, 2012·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Olafur S Palsson, William E Whitehead
Jun 12, 2013·Journal of Consulting and Clinical Psychology·Brjánn LjótssonErik Hedman
Feb 15, 2014·World Journal of Clinical Cases·Federico GobbiZeno Bisoffi
Mar 4, 2014·Gastroenterology·Emeran A MayerRobert J Shulman
Sep 16, 2014·Psychological Bulletin·Cecilia ChengMan-Pui Sally Chan
Sep 17, 2014·The American Journal of Gastroenterology·Jeffrey M LacknerUNKNOWN Representing the IBSOS Outcome Study Research Group
Oct 16, 2015·Clinical and Translational Gastroenterology·Christopher Radziwon, Jeffrey M Lackner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.